Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank93
3Y CAGR+2.9%
5Y CAGR+9.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+2.9%/yr
vs +21.4%/yr prior
5Y CAGR
+9.1%/yr
Recent deceleration
Acceleration
-18.5pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $491.72M | -11.9% |
| 2024 | $557.87M | +15.8% |
| 2023 | $481.87M | +6.7% |
| 2022 | $451.42M | +59.7% |
| 2021 | $282.66M | -11.1% |
| 2020 | $317.88M | +11.6% |
| 2019 | $284.81M | +37.1% |
| 2018 | $207.76M | +69.3% |
| 2017 | $122.68M | +46.5% |
| 2016 | $83.75M | - |